Cite
Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3.
MLA
Wan, Yuanyuan, et al. “Brusatol Induces Ferroptosis to Inhibit Hepatocellular Carcinoma Progression by Targeting ATF3.” Chemical Biology & Drug Design, vol. 103, no. 6, June 2024, pp. 1–17. EBSCOhost, https://doi.org/10.1111/cbdd.14565.
APA
Wan, Y., Cheng, J., Gan, D., He, J., Chen, A., Ma, J., Li, Y., Wang, X., Ran, J., Chen, D., & Li, J. (2024). Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3. Chemical Biology & Drug Design, 103(6), 1–17. https://doi.org/10.1111/cbdd.14565
Chicago
Wan, Yuanyuan, Jingsong Cheng, Debiao Gan, Jiaming He, An Chen, Jing Ma, Yunying Li, et al. 2024. “Brusatol Induces Ferroptosis to Inhibit Hepatocellular Carcinoma Progression by Targeting ATF3.” Chemical Biology & Drug Design 103 (6): 1–17. doi:10.1111/cbdd.14565.